Impact of diet and stress on the development of preeclampsia-like symptoms in p57kip2 mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 1, 2009, Pages

  Falcao, Stéphanie ^a,b   Solomon, Crina ^a,b   Monat, Caroline ^a   Bérubé, Julie ^a   Gutkowska, Jolanta ^a,b   Lavoie, Julie L ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Blood pressure; Diet; Knockout mouse; Preeclampsia; Stress

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CELL CYCLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIETARY INTAKE; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL FACTOR; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEREDITY; HYPERTENSION; IMMOBILIZATION STRESS; JAPANESE; MALE; MOUSE; NONHUMAN; NORTH AMERICA; PATHOLOGY; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; STRESS; SYMPTOM;

ANIMALS; BLOOD PRESSURE; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DIET; ENVIRONMENT; FEMALE; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 58149500132     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01011.2008     Document Type: Article

References (38)

1. Alexander BT, Kassab SE, Miller MT, Abram SR, Reckelhoff JF, Bennett WA, Granger JP. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37: 1191-1195, 2001.
2. Barron LA, Giardina JB, Granger JP, Khalil RA. High-salt diet enhances vascular reactivity in pregnant rats with normal and reduced uterine perfusion pressure. Hypertension 38: 730-735, 2001.
3. Coussons-Read ME, Okun ML, Nettles CD. Psychosocial stress increases inflammatory markers and alters cytokine production across pregnancy. Brain Behav Immun 21: 343-350, 2007.
4. Cross JC. The genetics of pre-eclampsia: a feto-placental or maternal problem? Clin Genet 64: 96-103, 2003.
5. Duley L, Henderson-Smart D, Meher S. Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database Syst Rev CD005548, 2005.
6. Falcao S, Bisotto S, Gutkowska J, Lavoie JL. Hyperhomocysteinemia is not sufficient to cause preeclampsia in an animal model; the importance of folate intake. Am J Obstetrics Gynecol. In press.
7. Fisher SJ. The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol 2: 53, 2004.
8. Frohlich ED. The salt conundrum: a hypothesis. Hypertension 50: 161-166, 2007.
9. Grimble RF. Nutritional modulation of cytokine biology. Nutrition 14: 634-640, 1998.
10. Gross V, Luft FC. Exercising restraint in measuring blood pressure in conscious mice. Hypertension 41: 879-881, 2003.
11. Haelterman E, Marcoux S, Croteau A, Dramaix M. Population-based study on occupational risk factors for preeclampsia and gestational hypertension. Scand J Work Environ Health 33: 304-317, 2007.
12. Hatada I, Mukai T. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet 11: 204-206, 1995.
13. Hoppe CC, Moritz KM, Fitzgerald SM, Bertram JF, Evans RG. Transient hypertension and sustained tachycardia in mice housed individually in metabolism cages. Physiol Res. In press.
14. Jones CJ, Fox H. An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta 1: 61-76, 1980.
15. Kanayama N, Takahashi K, Matsuura T, Sugimura M, Kobayashi T, Moniwa N, Tomita M, Nakayama K. Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod 8: 1129-1135, 2002.
16. Klonoff-Cohen HS, Cross JL, Pieper CF. Job stress and preeclampsia. Epidemiology 7: 245-249, 1996.
17. Knox KS, Baker JC. Genome-wide expression profiling of placentas in the p57Kip2 model of pre-eclampsia. Mol Hum Reprod 13: 251-263, 2007.
18. Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE. Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee. Arterioscler Thromb Vasc Biol 25: 478-479, 2005.
19. Landsbergis PA, Hatch MC. Psychosocial work stress and pregnancy-induced hypertension. Epidemiology 7: 346-351, 1996.
20. Lavoie JL. Pression artérielle chez la souris avec un nouveau transmetteur miniaturisé. Sci Tech Anim Lab 4: 1-3, 2006.
21. Leeners B, Neumaier-Wagner P, Kuse S, Stiller R, Rath W. Emotional stress and the risk to develop hypertensive diseases in pregnancy. Hypertens Pregnancy 26: 211-226, 2007.
22. Morgan T, Ward K. New insights into the genetics of preeclampsia. Semin Perinatol 23: 14-23, 1999.
23. Moutquin JM, Garner PR, Burrows RF, Rey E, Helewa ME, Lange IR, Rabkin SW. Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. CMAJ 157: 907-919, 1997.
24. Mulder EJ, Robles de Medina PG, Huizink AC, Van den Bergh BR, Buitelaar JK, Visser GH. Prenatal maternal stress: effects on pregnancy and the (unborn) child. Early Hum Dev 70: 3-14, 2002.
25. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 195: 40-49, 2006.
26. Pelaez LI, Manriquez MC, Nath KA, Romero JC, Juncos LA. Low-dose angiotensin II enhances pressor responses without causing sustained hypertension. Hypertension 42: 798-801, 2003.
27. Poston L. Endothelial dysfunction in pre-eclampsia. Pharmacol Rep 58, Suppl: 69-74, 2006.
28. Redline RW, Patterson P. Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum Pathol 26: 594-600, 1995.
29. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response: a review. Placenta 24: S21-S27, 2003.
30. Roberts JM, Balk JL, Bodnar LM, Belizan JM, Bergel E, Martinez A. Nutrient involvement in preeclampsia. J Nutr 133: 1684S-1692S, 2003.
31. Roberts JM, Lain KY. Recent Insights into the pathogenesis of pre-eclampsia. Placenta 23: 359-372, 2002.
32. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet 2: 538-548, 2001.
33. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Pre-eclampsia: a state of sympathetic overactivity. N Engl J Med 335: 1480-1485, 1996.
34. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 365: 785-799, 2005.
35. Takahashi K, Nakayama K, Nakayama K. Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation. J Biochem (Tokyo) 127: 73-83, 2000.
36. Takase H, Moreau P, Kung CF, Nava E, Luscher TF. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril. Hypertension 27: 25-31, 1996.
37. Wexler BC. Low protein fish vs. low protein animal diet enhances the propensity for stroke in stroke-prone/SHR. Stroke 14: 585-590, 1983.
38. Zhang P, Liegeois NJ, Wong C, Finegold M, Hou H, Thompson JC, Silverman A, Harper JW, DePinho RA, Elledge SJ. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387: 151-158, 1997.